Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine?

Molecularly imprinted polymers (MIPs) have been widely used in nanomedicine in the last few years. However, their potential is limited by their intrinsic properties resulting, for instance, in lack of control in drug release processes or complex detection for in vivo imaging. Recent attempts in crea...

Full description

Saved in:
Bibliographic Details
Published in:Nanomaterials (Basel, Switzerland) Switzerland), 2021-11, Vol.11 (11), p.3091
Main Authors: Garnier, Maylis, Sabbah, Michèle, Ménager, Christine, Griffete, Nébéwia
Format: Article
Language:English
Subjects:
Antibodies
Binding sites
Biochemistry, Molecular Biology
Biocompatibility
Cancer therapies
drug delivery
Enzymes
hybrid material
Imprinted polymers
Life Sciences
molecularly imprinted polymer
Nanomaterials
nanomedicine
Nanoparticles
Nanotechnology
Polymers
Quantum dots
Review
Sensors
targeting
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Molecularly imprinted polymers (MIPs) have been widely used in nanomedicine in the last few years. However, their potential is limited by their intrinsic properties resulting, for instance, in lack of control in drug release processes or complex detection for in vivo imaging. Recent attempts in creating hybrid nanomaterials combining MIPs with inorganic nanomaterials succeeded in providing a wide range of new interesting properties suitable for nanomedicine. Through this review, we aim to illustrate how hybrid molecularly imprinted polymers may improve patient care with enhanced imaging, treatments, and a combination of both.
ISSN:2079-4991
2079-4991
DOI:10.3390/nano11113091